Click for best price
Tuberculosis Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 1197.6 million
|
Forecast Market size by 2029 |
US$ 1613.9 million
|
| Growth Rate |
CAGR of 4.4% |
Number of Pages |
77 Pages |
Tuberculosis Drugs are used to treat tuberculosis.Tuberculosis is a chronic condition that is often undermined, though it can be fatal if left unchecked.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Drugs. This report contains market size and forecasts of Tuberculosis Drugs in global, including the following market information:
Global Tuberculosis Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Tuberculosis Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Tuberculosis Drugs companies in 2022 (%)
The global Tuberculosis Drugs market was valued at US$ 1197.6 million in 2022 and is projected to reach US$ 1613.9 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Government and non-governmental organizations alike are focusing on developing tuberculosis preventive treatment and increasing their access to the general populace. Thus, it would boost the tuberculosis drugs market over the forecast period.
We surveyed the Tuberculosis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tuberculosis Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Tuberculosis Drugs Market Segment Percentages, by Type, 2022 (%)
First Line Drugs Therapy
Second Line Drugs Therapy
Combination Drugs Therapy
Global Tuberculosis Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Tuberculosis Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Private Clinic
Others
Global Tuberculosis Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Tuberculosis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tuberculosis Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Tuberculosis Drugs revenues share in global market, 2022 (%)
Key companies Tuberculosis Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Tuberculosis Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc
Lupin Laboratories Ltd
AstraZeneca Plc
Cadila Pharmaceuticals
Novartis AG
Alkem Laboratories Ltd
Cipla Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tuberculosis Drugs, market overview.
Chapter 2: Global Tuberculosis Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Tuberculosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tuberculosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Tuberculosis Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Tuberculosis Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 1197.6 million
|
| Forecast Market size by 2029 |
US$ 1613.9 million
|
| Growth Rate |
CAGR of 4.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
77 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tuberculosis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tuberculosis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tuberculosis Drugs Overall Market Size
2.1 Global Tuberculosis Drugs Market Size: 2022 VS 2029
2.2 Global Tuberculosis Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Tuberculosis Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Tuberculosis Drugs Players in Global Market
3.2 Top Global Tuberculosis Drugs Companies Ranked by Revenue
3.3 Global Tuberculosis Drugs Revenue by Companies
3.4 Global Tuberculosis Drugs Sales by Companies
3.5 Global Tuberculosis Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Tuberculosis Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Tuberculosis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tuberculosis Drugs Players in Global Market
3.8.1 List of Global Tier 1 Tuberculosis Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Tuberculosis Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tuberculosis Drugs Market Size Markets, 2022 & 2029
4.1.2 First Line Drugs Therapy
4.1.3 Second Line Drugs Therapy
4.1.4 Combination Drugs Therapy
4.2 By Type - Global Tuberculosis Drugs Revenue & Forecasts
4.2.1 By Type - Global Tuberculosis Drugs Revenue, 2018-2023
4.2.2 By Type - Global Tuberculosis Drugs Revenue, 2024-2029
4.2.3 By Type - Global Tuberculosis Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Tuberculosis Drugs Sales & Forecasts
4.3.1 By Type - Global Tuberculosis Drugs Sales, 2018-2023
4.3.2 By Type - Global Tuberculosis Drugs Sales, 2024-2029
4.3.3 By Type - Global Tuberculosis Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Tuberculosis Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tuberculosis Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Private Clinic
5.1.4 Others
5.2 By Application - Global Tuberculosis Drugs Revenue & Forecasts
5.2.1 By Application - Global Tuberculosis Drugs Revenue, 2018-2023
5.2.2 By Application - Global Tuberculosis Drugs Revenue, 2024-2029
5.2.3 By Application - Global Tuberculosis Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Tuberculosis Drugs Sales & Forecasts
5.3.1 By Application - Global Tuberculosis Drugs Sales, 2018-2023
5.3.2 By Application - Global Tuberculosis Drugs Sales, 2024-2029
5.3.3 By Application - Global Tuberculosis Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Tuberculosis Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Tuberculosis Drugs Market Size, 2022 & 2029
6.2 By Region - Global Tuberculosis Drugs Revenue & Forecasts
6.2.1 By Region - Global Tuberculosis Drugs Revenue, 2018-2023
6.2.2 By Region - Global Tuberculosis Drugs Revenue, 2024-2029
6.2.3 By Region - Global Tuberculosis Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Tuberculosis Drugs Sales & Forecasts
6.3.1 By Region - Global Tuberculosis Drugs Sales, 2018-2023
6.3.2 By Region - Global Tuberculosis Drugs Sales, 2024-2029
6.3.3 By Region - Global Tuberculosis Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Tuberculosis Drugs Revenue, 2018-2029
6.4.2 By Country - North America Tuberculosis Drugs Sales, 2018-2029
6.4.3 US Tuberculosis Drugs Market Size, 2018-2029
6.4.4 Canada Tuberculosis Drugs Market Size, 2018-2029
6.4.5 Mexico Tuberculosis Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Tuberculosis Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Tuberculosis Drugs Sales, 2018-2029
6.5.3 Germany Tuberculosis Drugs Market Size, 2018-2029
6.5.4 France Tuberculosis Drugs Market Size, 2018-2029
6.5.5 U.K. Tuberculosis Drugs Market Size, 2018-2029
6.5.6 Italy Tuberculosis Drugs Market Size, 2018-2029
6.5.7 Russia Tuberculosis Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Tuberculosis Drugs Market Size, 2018-2029
6.5.9 Benelux Tuberculosis Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Tuberculosis Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Tuberculosis Drugs Sales, 2018-2029
6.6.3 China Tuberculosis Drugs Market Size, 2018-2029
6.6.4 Japan Tuberculosis Drugs Market Size, 2018-2029
6.6.5 South Korea Tuberculosis Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Tuberculosis Drugs Market Size, 2018-2029
6.6.7 India Tuberculosis Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Tuberculosis Drugs Revenue, 2018-2029
6.7.2 By Country - South America Tuberculosis Drugs Sales, 2018-2029
6.7.3 Brazil Tuberculosis Drugs Market Size, 2018-2029
6.7.4 Argentina Tuberculosis Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tuberculosis Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Tuberculosis Drugs Sales, 2018-2029
6.8.3 Turkey Tuberculosis Drugs Market Size, 2018-2029
6.8.4 Israel Tuberculosis Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Tuberculosis Drugs Market Size, 2018-2029
6.8.6 UAE Tuberculosis Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc
7.1.1 Pfizer Inc Company Summary
7.1.2 Pfizer Inc Business Overview
7.1.3 Pfizer Inc Tuberculosis Drugs Major Product Offerings
7.1.4 Pfizer Inc Tuberculosis Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Inc Key News & Latest Developments
7.2 Lupin Laboratories Ltd
7.2.1 Lupin Laboratories Ltd Company Summary
7.2.2 Lupin Laboratories Ltd Business Overview
7.2.3 Lupin Laboratories Ltd Tuberculosis Drugs Major Product Offerings
7.2.4 Lupin Laboratories Ltd Tuberculosis Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Lupin Laboratories Ltd Key News & Latest Developments
7.3 AstraZeneca Plc
7.3.1 AstraZeneca Plc Company Summary
7.3.2 AstraZeneca Plc Business Overview
7.3.3 AstraZeneca Plc Tuberculosis Drugs Major Product Offerings
7.3.4 AstraZeneca Plc Tuberculosis Drugs Sales and Revenue in Global (2018-2023)
7.3.5 AstraZeneca Plc Key News & Latest Developments
7.4 Cadila Pharmaceuticals
7.4.1 Cadila Pharmaceuticals Company Summary
7.4.2 Cadila Pharmaceuticals Business Overview
7.4.3 Cadila Pharmaceuticals Tuberculosis Drugs Major Product Offerings
7.4.4 Cadila Pharmaceuticals Tuberculosis Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Cadila Pharmaceuticals Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Tuberculosis Drugs Major Product Offerings
7.5.4 Novartis AG Tuberculosis Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 Alkem Laboratories Ltd
7.6.1 Alkem Laboratories Ltd Company Summary
7.6.2 Alkem Laboratories Ltd Business Overview
7.6.3 Alkem Laboratories Ltd Tuberculosis Drugs Major Product Offerings
7.6.4 Alkem Laboratories Ltd Tuberculosis Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Alkem Laboratories Ltd Key News & Latest Developments
7.7 Cipla Ltd
7.7.1 Cipla Ltd Company Summary
7.7.2 Cipla Ltd Business Overview
7.7.3 Cipla Ltd Tuberculosis Drugs Major Product Offerings
7.7.4 Cipla Ltd Tuberculosis Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Cipla Ltd Key News & Latest Developments
8 Global Tuberculosis Drugs Production Capacity, Analysis
8.1 Global Tuberculosis Drugs Production Capacity, 2018-2029
8.2 Tuberculosis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Tuberculosis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tuberculosis Drugs Supply Chain Analysis
10.1 Tuberculosis Drugs Industry Value Chain
10.2 Tuberculosis Drugs Upstream Market
10.3 Tuberculosis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tuberculosis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Tuberculosis Drugs in Global Market
Table 2. Top Tuberculosis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Tuberculosis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Tuberculosis Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Tuberculosis Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Tuberculosis Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Tuberculosis Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Tuberculosis Drugs Product Type
Table 9. List of Global Tier 1 Tuberculosis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tuberculosis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Tuberculosis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Tuberculosis Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Tuberculosis Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Tuberculosis Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Tuberculosis Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Tuberculosis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Tuberculosis Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Tuberculosis Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Tuberculosis Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Tuberculosis Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Tuberculosis Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Tuberculosis Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Tuberculosis Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Tuberculosis Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Tuberculosis Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Tuberculosis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Tuberculosis Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Tuberculosis Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Tuberculosis Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Tuberculosis Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Tuberculosis Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Tuberculosis Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Tuberculosis Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Tuberculosis Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Tuberculosis Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Tuberculosis Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Tuberculosis Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Tuberculosis Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Tuberculosis Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Tuberculosis Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Tuberculosis Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Tuberculosis Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Tuberculosis Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Tuberculosis Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Tuberculosis Drugs Sales, (K Units), 2024-2029
Table 46. Pfizer Inc Company Summary
Table 47. Pfizer Inc Tuberculosis Drugs Product Offerings
Table 48. Pfizer Inc Tuberculosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer Inc Key News & Latest Developments
Table 50. Lupin Laboratories Ltd Company Summary
Table 51. Lupin Laboratories Ltd Tuberculosis Drugs Product Offerings
Table 52. Lupin Laboratories Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Lupin Laboratories Ltd Key News & Latest Developments
Table 54. AstraZeneca Plc Company Summary
Table 55. AstraZeneca Plc Tuberculosis Drugs Product Offerings
Table 56. AstraZeneca Plc Tuberculosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. AstraZeneca Plc Key News & Latest Developments
Table 58. Cadila Pharmaceuticals Company Summary
Table 59. Cadila Pharmaceuticals Tuberculosis Drugs Product Offerings
Table 60. Cadila Pharmaceuticals Tuberculosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Cadila Pharmaceuticals Key News & Latest Developments
Table 62. Novartis AG Company Summary
Table 63. Novartis AG Tuberculosis Drugs Product Offerings
Table 64. Novartis AG Tuberculosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Novartis AG Key News & Latest Developments
Table 66. Alkem Laboratories Ltd Company Summary
Table 67. Alkem Laboratories Ltd Tuberculosis Drugs Product Offerings
Table 68. Alkem Laboratories Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Alkem Laboratories Ltd Key News & Latest Developments
Table 70. Cipla Ltd Company Summary
Table 71. Cipla Ltd Tuberculosis Drugs Product Offerings
Table 72. Cipla Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Cipla Ltd Key News & Latest Developments
Table 74. Tuberculosis Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global Tuberculosis Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Tuberculosis Drugs Production by Region, 2018-2023 (K Units)
Table 77. Global Tuberculosis Drugs Production by Region, 2024-2029 (K Units)
Table 78. Tuberculosis Drugs Market Opportunities & Trends in Global Market
Table 79. Tuberculosis Drugs Market Drivers in Global Market
Table 80. Tuberculosis Drugs Market Restraints in Global Market
Table 81. Tuberculosis Drugs Raw Materials
Table 82. Tuberculosis Drugs Raw Materials Suppliers in Global Market
Table 83. Typical Tuberculosis Drugs Downstream
Table 84. Tuberculosis Drugs Downstream Clients in Global Market
Table 85. Tuberculosis Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Tuberculosis Drugs Segment by Type in 2022
Figure 2. Tuberculosis Drugs Segment by Application in 2022
Figure 3. Global Tuberculosis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Tuberculosis Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Tuberculosis Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Tuberculosis Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Tuberculosis Drugs Revenue in 2022
Figure 9. By Type - Global Tuberculosis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Tuberculosis Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Tuberculosis Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Tuberculosis Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Tuberculosis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Tuberculosis Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Tuberculosis Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Tuberculosis Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Tuberculosis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Tuberculosis Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Tuberculosis Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Tuberculosis Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Tuberculosis Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Tuberculosis Drugs Sales Market Share, 2018-2029
Figure 23. US Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Tuberculosis Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Tuberculosis Drugs Sales Market Share, 2018-2029
Figure 28. Germany Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Tuberculosis Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Tuberculosis Drugs Sales Market Share, 2018-2029
Figure 37. China Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Tuberculosis Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Tuberculosis Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Tuberculosis Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Tuberculosis Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Tuberculosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Tuberculosis Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Tuberculosis Drugs by Region, 2022 VS 2029
Figure 54. Tuberculosis Drugs Industry Value Chain
Figure 55. Marketing Channels
